Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis

(2020) Dandan Zhao et al.   Cancer Cell International

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients

(2020) Orit Itzhaki et al.   Journal for ImmunoTherapy of Cancer

Mechanisms of resistance to CAR T cell therapy

(2019) Nirali N. Shah et al.   Nature Reviews Clinical Oncology

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

(2019) Mohamad Hamieh et al.   NATURE

Updates on CAR T-cell therapy in B-cell malignancies

(2019) Elad Jacoby et al.   IMMUNOLOGICAL REVIEWS

Chimeric antigen receptor–modified T cells: CD19 and the road beyond

(2018) Alexander I. Salter et al.   BLOOD

Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma

(2018) Haneen Shalabi et al.   HAEMATOLOGICA

Chimeric Antigen Receptor Therapy

(2018) Carl H. June et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma

(2018) Haneen Shalabi et al.   HAEMATOLOGICA

Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia

(2018) Elad Jacoby et al.   AMERICAN JOURNAL OF HEMATOLOGY

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

(2017) Alec J. Walker et al.   MOLECULAR THERAPY

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

(2016) Meenakshi Hegde et al.   JOURNAL OF CLINICAL INVESTIGATION

   T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-  +/CD19+ lymphocytes

(2015) I. Airoldi et al.   BLOOD

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy

(2015) Mateusz Legut et al.   Cellular & Molecular Immunology

Clinical Applications of Gamma Delta T Cells with Multivalent Immunity

(2014) Drew C. Deniger et al.   Frontiers in Immunology

Repeated Systemic Administrations of Both Aminobisphosphonates and Human V 9V 2 T Cells Efficiently Control Tumor Development In Vivo

(2013) T. Santolaria et al.   JOURNAL OF IMMUNOLOGY

Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor

(2013) Drew C Deniger et al.   MOLECULAR THERAPY

Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy

(2013) Maria Themeli et al.   NATURE BIOTECHNOLOGY

What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

(2012) Jean-Jacques Fournié et al.   Cellular & Molecular Immunology